MEDNAX Inc
NYSE:MD
Relative Value
The Relative Value of one
MD
stock under the Base Case scenario is
23.32
USD.
Compared to the current market price of 19.46 USD,
MEDNAX Inc
is
Undervalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MD Competitors Multiples
MEDNAX Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
MEDNAX Inc
NYSE:MD
|
1.6B USD | 0.8 | 9.6 | 6.6 | 7.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
101.2B USD | 0.3 | 57.2 | 14.4 | 14.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
64.9B EUR | 0.3 | 12.4 | 7.9 | 10.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.2B USD | 0.3 | 12.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.8B EUR | 1.3 | 26.1 | 10.9 | 16.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.3B EUR | 1.3 | 34.4 | 10.2 | 21.9 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.7B USD | 1.7 | 27.2 | 12.9 | 18.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.4B USD | 2.1 | 23.6 | 12.9 | 17.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.4B EUR | 0.6 | 15.8 | 6.3 | 13.4 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.3B USD | 12.5 | -29.6 | -31.7 | -28.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.7B USD | 0.8 | 14.4 | 7.4 | 10.1 |